Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Monika Killer, Eugen Trinka, Jörg Kraus & Erasmia Broussalis. (2011) Discovery, development and effectiveness of coagulation-inhibiting drugs for stroke therapy. Expert Opinion on Drug Discovery 6:4, pages 353-369.
Read now
Read now
Articles from other publishers (20)
Rohi Shah, Nomaan Sheikh, Jitendra Mangwani, Nicolette Morgan & Hamidreza Khairandish. (2021) Direct oral anticoagulants (DOACs) and neck of femur fractures: Standardising the perioperative management and time to surgery. Journal of Clinical Orthopaedics and Trauma 12:1, pages 138-147.
Crossref
Crossref
Zhao-Yu Wu, Hao Zhang, Yi-Yao Yang & Feng-Qing Yang. (2020) An online dual-enzyme co-immobilized microreactor based on capillary electrophoresis for enzyme kinetics assays and screening of dual-target inhibitors against thrombin and factor Xa. Journal of Chromatography A 1619, pages 460948.
Crossref
Crossref
Elzbieta Mlodawska, Paulina Lopatowska, Jolanta Malyszko, Maciej Banach, Bożena Sobkowicz, Adrian Covic & Anna Tomaszuk-Kazberuk. (2018) Atrial fibrillation in dialysis patients: is there a place for non-vitamin K antagonist oral anticoagulants?. International Urology and Nephrology 50:9, pages 1633-1642.
Crossref
Crossref
Qiao-Qiao Li, Feng-Qing Yang, Yin-Zhen Wang, Zhao-Yu Wu, Zhi-Ning Xia & Hua Chen. (2018) Evaluation of thrombin inhibitory activity of catechins by online capillary electrophoresis-based immobilized enzyme microreactor and molecular docking. Talanta 185, pages 16-22.
Crossref
Crossref
Nicola Mumoli, Daniela Mastroiacovo, Eleonora Tamborini-Permunian, Josè Vitale, Matteo Giorgi-Pierfranceschi, Marco Cei & Francesco Dentali. (2017) Dabigatran in nonvalvular atrial fibrillation. Journal of Cardiovascular Medicine 18:7, pages 467-477.
Crossref
Crossref
Seher Kcükköylü & Lars Rump. (2017) DOAC use in patients with chronic kidney disease. Hämostaseologie 37:04, pages 286-294.
Crossref
Crossref
Fei Wang, Yu-Jie Ren & Ming-Hui Dong. (2016) Molecular design, synthesis and anticoagulant activity evaluation of fluorinated dabigatran analogues. Bioorganic & Medicinal Chemistry 24:12, pages 2739-2753.
Crossref
Crossref
Timothy W. Chang, Christopher J. Arpey, Christian L. Baum, Jerry D. Brewer, Phillip C. Hochwalt, Thomas L. Hocker, Randall K. Roenigk & Clark C. Otley. (2015) Complications With New Oral Anticoagulants Dabigatran and Rivaroxaban in Cutaneous Surgery. Dermatologic Surgery 41:7, pages 784-793.
Crossref
Crossref
Jun Lu, Hui-Peng Song, Ping Li, Ping Zhou, Xin Dong & Jun Chen. (2015) Screening of direct thrombin inhibitors from Radix Salviae Miltiorrhizae by a peak fractionation approach. Journal of Pharmaceutical and Biomedical Analysis 109, pages 85-90.
Crossref
Crossref
Pietro Francia, Carmen Adduci, Daria Santini, Beatrice Musumeci & Giuliano Tocci. (2013) New Oral Anticoagulants in Non-Valvular Atrial Fibrillation. High Blood Pressure & Cardiovascular Prevention 20:2, pages 53-60.
Crossref
Crossref
Arne Ring, Karin Rathgen, Joachim Stangier, Paul Reilly, Andreas Clemens & Jeffrey Friedman. (2013) Dabigatran Does Not Prolong the QT Interval with Supratherapeutic Exposure: a Thorough QT Study in Healthy Subjects. Clinical Drug Investigation 33:5, pages 333-342.
Crossref
Crossref
Christopher S. King, Aaron B. Holley & Lisa K. Moores. (2013) Moving Toward a More Ideal Anticoagulant. Chest 143:4, pages 1106-1116.
Crossref
Crossref
Hana Línková & Róbert Petr. (2013) Antithrombotic therapy in valvular heart disease and artificial valves. Cor et Vasa 55:2, pages e158-e163.
Crossref
Crossref
Shawn E. Fellows, Jamie M. Rosini, James A. Curtis & Emilio G. Volz. (2013) Hemorrhagic Gastritis with Dabigatran in a Patient with Renal Insufficiency. The Journal of Emergency Medicine 44:2, pages e221-e225.
Crossref
Crossref
Marc Fisher & Mehmet Zülküf Önal. 2013. Vascular Medicine: A Companion to Braunwald's Heart Disease. Vascular Medicine: A Companion to Braunwald's Heart Disease
372
385
.
James P. Bota, Keith G. LeBlanc & Daniel J. Sheehan. (2012) Dabigatran Etexilate: Clinical Implications in Dermatologic Surgery. Dermatologic Surgery 38:4, pages 675-676.
Crossref
Crossref
Erasmia Broussalis, Monika Killer, Mark McCoy, Andrea Harrer, Eugen Trinka & Jörg Kraus. (2012) Current therapies in ischemic stroke. Part A. Recent developments in acute stroke treatment and in stroke prevention. Drug Discovery Today 17:7-8, pages 296-309.
Crossref
Crossref
D Kendoff, C Perka, H.M Fritsche, T Gehrke & R Hube. (2011) Oral Thromboprophylaxis Following Total Hip or Knee Replacement: Review and Multicentre Experience with Dabigatran Etexilate. The Open Orthopaedics Journal 5:1, pages 395-399.
Crossref
Crossref
J.M. Calvo Romero & E.M. Lima Rodríguez. (2011) Indicaciones del dabigatrán. SEMERGEN - Medicina de Familia 37:5, pages 252-254.
Crossref
Crossref
J.M. Calvo Romero. (2011) ¿Dabigatrán o antagonistas de la vitamina K en la prevención de ictus en pacientes con fibrilación auricular?. Revista Clínica Española 211:3, pages 142-146.
Crossref
Crossref